...
机译:生物反应器工艺变量和纯化对来自中国仓鼠卵巢细胞产生的人重组溶酶体酶β-葡糖醛酸酶的差异
US FDA Off Testing &
Res Ctr Drug Evaluat &
Res Silver Spring MD 20993 USA;
US FDA Off Testing &
Res Ctr Drug Evaluat &
Res Silver Spring MD 20993 USA;
US FDA Off Biotechnol Prod Ctr Drug Evaluat &
Res Silver Spring MD 20993 USA;
US FDA Off Testing &
Res Ctr Drug Evaluat &
Res Silver Spring MD 20993 USA;
US FDA Off Biotechnol Prod Ctr Drug Evaluat &
Res Silver Spring MD 20993 USA;
US FDA Off Testing &
Res Ctr Drug Evaluat &
Res Silver Spring MD 20993 USA;
US FDA Off Biotechnol Prod Ctr Drug Evaluat &
Res Silver Spring MD 20993 USA;
US FDA Off Testing &
Res Ctr Drug Evaluat &
Res Silver Spring MD 20993 USA;
Enzyme replacement therapy; Lysosomal storage disorders; Parallel bioreactors; Glycan content; Mannose-6-phosphate; beta-Glucuronidase; Chinese hamster ovary cells; Critical quality attributes;
机译:生物反应器工艺变量和纯化对来自中国仓鼠卵巢细胞产生的人重组溶酶体酶β-葡糖醛酸酶的差异
机译:中国仓鼠卵巢细胞中重组人血管生成素-1的表达与纯化
机译:中国仓鼠卵巢细胞中重组人血管生成素-1的表达与纯化
机译:XBP1过表达对DMSO重组中国仓鼠卵巢(CHO)细胞乙型肝炎表面抗原(HbsAg)细胞内积累的影响
机译:从转染的中国仓鼠卵巢(CHO)细胞系生产重组人β干扰素(β-IFN)的细胞培养方法的开发
机译:溶酶体生物治疗性重组蛋白表达对中国仓鼠卵巢细胞应激和蛋白酶及一般宿主细胞蛋白释放的影响
机译:溶酶体生物治疗性重组蛋白表达对中国仓鼠卵巢细胞应激和蛋白酶及普通宿主细胞蛋白(HCP)释放的影响